- Home
- CDT vs ABTS Comparison
CDT vs ABTS Comparison
Compare CDT & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- ABTS
- Stock Information
- Founded
- CDT 2019
- ABTS 2010
- Country
- CDT United States
- ABTS Hong Kong
- Employees
- CDT N/A
- ABTS N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- CDT Health Care
- ABTS Technology
- Exchange
- CDT Nasdaq
- ABTS Nasdaq
- Market Cap
- CDT 5.3M
- ABTS 4.6M
- IPO Year
- CDT N/A
- ABTS N/A
- Fundamental
- Price
- CDT $0.39
- ABTS $3.79
- Analyst Decision
- CDT
- ABTS
- Analyst Count
- CDT 0
- ABTS 0
- Target Price
- CDT N/A
- ABTS N/A
- AVG Volume (30 Days)
- CDT 768.1K
- ABTS 366.3K
- Earning Date
- CDT 05-15-2025
- ABTS 12-31-2024
- Dividend Yield
- CDT N/A
- ABTS N/A
- EPS Growth
- CDT N/A
- ABTS N/A
- EPS
- CDT N/A
- ABTS N/A
- Revenue
- CDT N/A
- ABTS $6,711,225.00
- Revenue This Year
- CDT N/A
- ABTS N/A
- Revenue Next Year
- CDT N/A
- ABTS N/A
- P/E Ratio
- CDT N/A
- ABTS N/A
- Revenue Growth
- CDT N/A
- ABTS 299.11
- 52 Week Low
- CDT $0.51
- ABTS $0.25
- 52 Week High
- CDT $350.00
- ABTS $4.19
- Technical
- Relative Strength Index (RSI)
- CDT 31.63
- ABTS 53.78
- Support Level
- CDT $0.38
- ABTS $2.91
- Resistance Level
- CDT $0.41
- ABTS $9.40
- Average True Range (ATR)
- CDT 0.04
- ABTS 1.01
- MACD
- CDT 0.01
- ABTS 0.03
- Stochastic Oscillator
- CDT 9.89
- ABTS 21.54
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.